Actavis Dapsone 50mg Tablets

Actavis Dapsone 50mg is a generic antibacterial medication primarily used to treat conditions like leprosy and dermatitis herpetiformis. The brand 'Actavis' has a complex corporate history. It was significantly shaped by the 2012 acquisition of the Swiss-based Actavis Group by Watson Pharmaceuticals, which then adopted the Actavis name due to its strong global recognition.

In 2015, Actavis acquired the pharmaceutical giant Allergan and subsequently changed its own corporate name to Allergan plc. However, the generic medicine portfolio continued to be marketed under the 'Actavis' brand. A major shift occurred in 2016 when Teva Pharmaceutical Industries, an Israeli multinational, acquired the Actavis Generics business from Allergan for approximately $40.5 billion. As of 2026, the Actavis brand and its generic products are under the ultimate ownership of Teva Pharmaceutical Industries Ltd. Manufacturing occurs in multiple locations globally, including India, the United States, and Europe, depending on the specific regional distribution and regulatory approvals.